Sponsors

CAMEL would like to thank the following sponsors for their generous support of our research program.

  • American Cancer Society
  • Anne Rita Monahan Foundation, Phoenix AZ
  • Arizona Biomedical Research Commission
  • Better Than Ever Program, University of Arizona Cancer Center
  • Case Western Reserve University
  • Community Foundation of Southern Arizona
  • Department of Defense CDMRP Breast Cancer Research Program
  • National Institute of Biomedical Imaging and Bioengineering, NIH
  • National Cancer Institute, NIH
  • Ohio BRTT Program
  • Phoenix Friends of the Arizona Cancer Center
  • University of Arizona Cancer Center
  • Wallace A. Coulter Foundation

Current Research Support:

Title: Measuring extracellular pH in pre-clinical tumor models with CEST MRI
Dates: 4/1/12-2/28/16
Principal Investigator: M. Pagel
Agency: NCI/NIH
Grant Number: R01CA167183
Summary: This proposal will develop CEST agents and improve CEST MRI methods that measure extracellular pH in the tumor microenvironment within pre-clinical cancer models.


Title: Detection of in vivo enzyme activities with CEST MRI
Dates: 7/1/12-5/31/17
Principal Investigator: M. Pagel
Agency: NCI/NIH
Grant Number: 1R01CA169774-01
Summary: This proposal will develop CEST agents and improve CEST MRI methods that detect enzyme activities in pre-clinical cancer models.


Title: Early phase clinical trial for imaging tumor acidosis in breast cancer patients using acidoCEST MRI
Dates 7/1/15-6/30/17
Principal Investigator: M. Pagel
Agency: NCI/NIH in response to PAR-14-166
Grant Number: 1R01CA197029
Summary: The proposed research applies our clinical acidoCEST MRI method to evaluate the extracellular pH in solid tumors to improve the diagnosis and early assessments of chemotherapies in patients with breast cancer.